| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.7 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |